Chlorambucil plus Rituximab as Front-Line Therapy in Elderly/Unfit Patients Affected by B-Cell Chronic Lymphocytic Leukemia: Results of a Single-Centre Experience

The current standard first line therapy for fit patients with B-CLL/SLL is based on combination of fludarabine-cyclophosphamide and rituximab. However, elderly patients or patients with comorbidities poorly tolerate purine analogue-based chemotherapy and they are often treated with Chlorambucil (Chl...

Descripción completa

Detalles Bibliográficos
Autores principales: Laurenti, Luca, Vannata, Barbara, Innocenti, Idanna, Autore, Francesco, Santini, Francesco, Piccirillo, Nicola, Za, Tommaso, Bellesi, Silvia, Marietti, Sara, Sica, Simona, Efremov, Dimitar G., Leone, Giuseppe
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Università Cattolica del Sacro Cuore 2013
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3647714/
https://www.ncbi.nlm.nih.gov/pubmed/23667729
http://dx.doi.org/10.4084/MJHID.2013.031

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3647714/
https://www.ncbi.nlm.nih.gov/pubmed/23667729
http://dx.doi.org/10.4084/MJHID.2013.031

Ejemplares similares